LLY

1,027.44

+2.13%↑

JNJ

211.44

+0.72%↑

ABBV

223.45

-0.16%↓

UNH

341.39

+1.44%↑

AZN

89.79

-0.45%↓

LLY

1,027.44

+2.13%↑

JNJ

211.44

+0.72%↑

ABBV

223.45

-0.16%↓

UNH

341.39

+1.44%↑

AZN

89.79

-0.45%↓

LLY

1,027.44

+2.13%↑

JNJ

211.44

+0.72%↑

ABBV

223.45

-0.16%↓

UNH

341.39

+1.44%↑

AZN

89.79

-0.45%↓

LLY

1,027.44

+2.13%↑

JNJ

211.44

+0.72%↑

ABBV

223.45

-0.16%↓

UNH

341.39

+1.44%↑

AZN

89.79

-0.45%↓

LLY

1,027.44

+2.13%↑

JNJ

211.44

+0.72%↑

ABBV

223.45

-0.16%↓

UNH

341.39

+1.44%↑

AZN

89.79

-0.45%↓

Начало・Списък с акции・ResMed Inc

ResMed Inc

Затворен

СекторЗдравеопазване

251.86 0.1

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

250.08

Максимум

252.03

Ключови измерители
By Trading Economics
Приходи	-31M 349M
Продажби	-12M 1.3B
P/E Средно за сектора	25.567 77.671
EPS	2.55
Дивидентна доходност	0.85
Марж на печалбата	26.096
Служители	10,600
EBITDA	-29M 503M

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+20.37% upside

Дивиденти
By Dow Jones
Дивидентна доходност Средно за сектора	0.85% 2.35%
Следваща дата на дивидент	18.12.2025 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-1.3B 36B
Предишно отваряне	251.76
Предишно затваряне	251.86

Настроения в новините

By Acuity

19%

81%

27 / 374 Класиране в Healthcare

ResMed Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

14.12.2025 г., 22:53 ч. UTC

Придобивния, сливания и поглъщания

Fortescue to Take Full Control of US$101 Million Copper Miner Alta

13.12.2025 г., 00:04 ч. UTC

Придобивния, сливания и поглъщания

Intel in Talks to Acquire SambaNova in Deal Valued at $1.6 Billion, Bloomberg Reports, Citing Sources

14.12.2025 г., 23:46 ч. UTC

Пазарно говорене

Gold Edges Higher Amid Some Tailwinds -- Market Talk

14.12.2025 г., 23:36 ч. UTC

Пазарно говорене

Nikkei May Fall, Tracking Wall Street's Losses -- Market Talk

14.12.2025 г., 22:38 ч. UTC

Придобивния, сливания и поглъщания

Fortescue to Take Full Control of US$101M Copper Miner Alta

14.12.2025 г., 22:02 ч. UTC

Придобивния, сливания и поглъщания

Fortescue: Transaction Is Consistent With Critical Minerals Strategy

14.12.2025 г., 22:01 ч. UTC

Придобивния, сливания и поглъщания

Fortescue: Alta Owns the Canariaco Project in Northern Peru

14.12.2025 г., 22:01 ч. UTC

Придобивния, сливания и поглъщания

Fortescue: Alta Directors Unanimously Recommend Proposal, Will Vote in Favor

14.12.2025 г., 22:00 ч. UTC

Придобивния, сливания и поглъщания

Fortescue: Agreement Implies Total Equity Value of C$139 Million

14.12.2025 г., 22:00 ч. UTC

Придобивния, сливания и поглъщания

Fortescue to Pay C$1.40/Share for Securities It Does Not Already Own

14.12.2025 г., 21:59 ч. UTC

Придобивния, сливания и поглъщания

Fortescue to Acquire Remaining 64% of Alta Copper

14.12.2025 г., 17:00 ч. UTC

Печалби

Tonka Trucks Gambled on Keeping Production in China and Survived -- Barely -- WSJ

14.12.2025 г., 08:30 ч. UTC

Придобивния, сливания и поглъщания

Kymera Had a Big Week. This Secretive Hedge Fund Bought $172 Million of Its Stock. -- Barrons.com

13.12.2025 г., 16:48 ч. UTC

Придобивния, сливания и поглъщания

How the War to Win Warner Bros. Discovery Will Be Won -- Barrons.com

13.12.2025 г., 08:00 ч. UTC

Придобивния, сливания и поглъщания

How the War to Win Warner Bros. Discovery Will Be Won -- Barrons.com

13.12.2025 г., 07:00 ч. UTC

Придобивния, сливания и поглъщания

A Chubb/AIG Deal Could Be Good for Shareholders and a Coup for Greenberg Family -- Barrons.com

13.12.2025 г., 00:24 ч. UTC

Придобивния, сливания и поглъщания

Want a Piece Of SpaceX? -- Barrons.com

12.12.2025 г., 23:49 ч. UTC

Придобивния, сливания и поглъщания

Intel in Talks to Acquire SambaNova in Deal Valued at $1.6B, Bloomberg Reports, Citing Sources

12.12.2025 г., 22:52 ч. UTC

Пазарно говорене

Nike Expected to Show Further Momentum in 2Q Results -- Market Talk

12.12.2025 г., 22:32 ч. UTC

Печалби

These Stocks Moved the Most Today: Broadcom, Oracle, Fermi, Tilray, Lululemon, Costco, Netskope, and More -- Barrons.com

12.12.2025 г., 21:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

12.12.2025 г., 20:45 ч. UTC

Печалби

The Best Dividend ETF for Right Now -- and 2026 -- Barrons.com

12.12.2025 г., 20:41 ч. UTC

Пазарно говорене

Oil Ends Week Lower As Market Frets About Oversupply -- Market Talk

12.12.2025 г., 20:20 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures Post Hefty Weekly Loss -- Market Talk

12.12.2025 г., 19:23 ч. UTC

Печалби

Charles Schwab Is Opening New Accounts and Hauling in New Assets Amid Buoyant Stock Market -- Barrons.com

12.12.2025 г., 18:35 ч. UTC

Придобивния, сливания и поглъщания

PNC Financial Expects to Close FirstBank Deal On or About Jan. 5, Subject to Satisfaction of Customary Closing Conditions

12.12.2025 г., 18:33 ч. UTC

Придобивния, сливания и поглъщания

PNC Receives Regulatory Approvals For Acquisition Of FirstBank >PNC

12.12.2025 г., 18:31 ч. UTC

Пазарно говорене

U.S. Oil Rig Count Edges Up by 1 to 414 -- Market Talk

12.12.2025 г., 17:49 ч. UTC

Печалби

Tariffs Mean Costco Has Fewer Product Types This Holiday. But It Has Plenty of Pies. -- WSJ

12.12.2025 г., 17:34 ч. UTC

Придобивния, сливания и поглъщания

Orange: Closing Subject to Customary Regulatory Approvals, Other Closing Conditions

Сравнение с други в отрасъла

Ценова промяна

ResMed Inc Прогноза

Ценова цел

By TipRanks

20.37% нагоре

12-месечна прогноза

Среден 303.67 USD 20.37%

Висок 345 USD

Нисък 270 USD

Според 13 анализатори от Wall Street, предложили 12-месечна ценова цел за ResMed Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

13 ratings

Купи

Задържане

Продай

Според 13 анализатори, дали борсови рейтинги на ResMed Inc през последните 3 месеца.

Настроение

By Acuity

27 / 374 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.